Andrew Nam

Andrew Nam is an analyst at Eversept Partners in New York, where he focuses on public healthcare equities and investment research within the biotechnology and life sciences sectors. At Eversept, he contributes to fundamental analysis and sector strategy, supporting investment decisions in healthcare-focused portfolios.

Before joining Eversept Partners in 2020, Andrew served as an associate at Veritas Capital, a private equity firm with a focus on technology and government-related sectors, and as an analyst at J.P. Morgan where he gained experience in investment banking and capital markets. His background spans healthcare investing as well as broader experience in private equity and financial analysis, grounding him in both buy-side and sell-side disciplines.

Andrew holds a degree from Claremont McKenna College, equipping him with strong analytical and quantitative skills. His expertise centers around healthcare and biotechnology investments, with demonstrated capability in financial modeling, due diligence, and fundamental research across global healthcare markets.